Agtech Global International Inc. (Agtech) and KRTL Biotech Inc., (KRTL) to jointly announce that they have signed a Memorandum of Understanding to develop and distribute new CBD and Psilocybin compounds and ultimately unique medicines under development by KRTL?s team of US and Korean medical doctors and research scientists, for the treatment of a range of debilitating human disorders. These disorders include but are not limited to pain resulting from the treatment of certain cancers, autism, post-traumatic stress disorder, attention deficit hyperactivity disorder, depression, addiction, concentration improvement and other psychological illnesses just to name a few. KRTL Biotech Inc. obtained a Ministry of Food and Drug Safety (MFDS) approval (formerly KFDA), to commence researching compounds of Psilocybin and CBD (Project) that will better assist global populations in the treatment of specific debilitating disorders. KRTL and its affiliated companies are keen to support and expand Agtech?s market reach and promote its Virtual Retail Marketing Systems? and Genus? product range around the world and subject to satisfactory due diligence and funding capacity, AGGL is planning to make a $2,000,000 investment in KRTL to support this worthwhile Project.